ArticleCancer science2012

Targeting nuclear factor-κB suppresses the negative effect of toll-like receptor 4 signaling on antimetastasis therapy based on targeting αvβ3.

Jian-Hua Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.